Apps, J. R., & Martinez-Barbera, J. P. (2022). A promising future for hypothalamic dysfunction in craniopharyngioma. Neuro-Oncology, noac284. doi:10.1093/neuonc/noac284

Selt, F., Sigaud, R., Valinciute, G., Sievers, P., Zaman, J., Alco, C., . . . Milde, T. (2022). BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma. NEURO-ONCOLOGY. doi:10.1093/neuonc/noac199

Apps, J. R., Muller, H. L., Hankinson, T. C., Yock, T. I., & Martinez-Barbera, J. P. (2022). Contemporary Biological Insights and Clinical Management of Craniopharyngioma. Endocrine Reviews. doi:10.1210/endrev/bnac035

Müller, H. L., Tauber, M., Lawson, E. A., Özyurt, J., Bison, B., Martinez-Barbera, J. -. P., . . . van Santen, H. M. (2022). Hypothalamic syndrome. Nature Reviews Disease Primers, 8 (1), 24. doi:10.1038/s41572-022-00351-z

Gonzalez-Meljem, J. M., & Martinez-Barbera, J. P. (2021). Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis. Cellular and Molecular Life Sciences. doi:10.1007/s00018-021-03798-7

Carreno, G., Guiho, R., & Martinez-Barbera, J. P. (2021). Cell Senescence in Neuropathology: a Focus on Neurodegeneration and Tumours. Neuropathology and Applied Neurobiology. doi:10.1111/nan.12689

Apps, J. R., & Martinez-Barbera, J. P. (2021). Pathophysiology and genetics in craniopharyngioma. Pituitary Tumors: A Comprehensive and Interdisciplinary Approach (pp. 53-66). doi:10.1016/B978-0-12-819949-7.00020-2

Martinez-Barbera, J. P., & Andoniadou, C. L. (2020). Biological Behaviour of Craniopharyngiomas. Neuroendocrinology, 110 (9-10), 797-804. doi:10.1159/000506904

Apps, J. R., Stache, C., Gonzalez-Meljem, J. M., Gutteridge, A., Chalker, J., Jacques, T. S., . . . Martinez-Barbera, J. P. (2020). CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma. Neuropathol Appl Neurobiol. doi:10.1111/nan.12613

Guerrero, A., Guiho, R., Herranz, N., Uren, A., Withers, D. J., Martínez-Barbera, J. P., . . . Gil, J. (2020). Galactose-modified duocarmycin prodrugs as senolytics. Aging Cell. doi:10.1111/acel.13133